European Medicines Agency recommends that Protelos/Osseor remain available but with further restrictions (EMA, 21 February 2014)

25 Feb 2014


The EMA has concluded its review of Protelos/Osseor and has issued a press release recommending further restrictions for the drug.

Full article


Share this story